Micaela Bergamaschi
Ospedale Policlinico San Martino(IT)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population(2011)253 cited
- → Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis(2019)145 cited
- → Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib(2013)137 cited
- → Differences among young adults, adults and elderly chronic myeloid leukemia patients(2014)98 cited
- → Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis(2017)89 cited
- → Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP(2019)89 cited
- → Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells(2011)86 cited
- → Health‐related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease(2016)80 cited
- → Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice(2019)76 cited
- → Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation(2019)73 cited